PPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorElmaci, Ilhan
dc.contributor.authorHacimuftuoglu, Ahmet
dc.contributor.authorOzpinar, Alp
dc.contributor.authorHacker, Emily
dc.contributor.authorOzpinar, Aysel
dc.date.accessioned2025-10-16T15:19:36Z
dc.date.issued2021
dc.identifier.doi10.1016/j.mam.2020.100871
dc.identifier.otherWOS:000635168900001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7371
dc.publisherELSEVIER
dc.sourceMOLECULAR ASPECTS OF MEDICINE
dc.subjectPPAR
dc.subjectErucic acid
dc.subjectMelanoma
dc.subjectNeuroblastoma
dc.subjectGlioblastoma
dc.subjectParkinson \\?s disease
dc.titlePPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease
dc.typeReview

Dosyalar

Koleksiyonlar

WOS